万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>医卫科学>>肿瘤学
您的位置:万维书刊网 >>国内sci期刊>>医药卫生

中国癌症研究(英文版)(Chinese Journal of Cancer Research) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 CSCD核心(2023-2024), 高质量科技期刊(T1), 科技核心(2024自然科学), SCIE核心, 维普收录, 万方收录, 知网收录,第一批认定学术期刊,外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

《中国癌症研究(英文版)》(Chinese Journal of Cancer Research)(双月刊)创刊于1988年,由中国抗癌协会主办。作为国内主要的英文肿瘤学期刊,面向国际介绍我国肿瘤防治研究在基础理论和临床诊断治疗以及癌症控制与预防各个领域所取得的学术成果和新近进展,旨在反映我国癌症研究的概貌,促进国内外学术交流,推动我国抗癌事业的发展。主要刊载肿瘤学包括其各分支学科的研究论文,内容...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、刊内网址(202502期):https://www.cjcrcn.org

  投稿系统:

  http://mc03.manuscriptcentral.com/cjcr

3、官网邮箱:editor@cjcrcn.org

4、官网电话:010-88196612

5、出刊日期:双月刊,逢双月出版。

6、官网微信公众号:中国癌症研究英文杂志(chjcacnr

202571日星期二

                        

 

《中国癌症研究(英文)》投稿须知

官网信息】

 

Author Instruction

Cbinese Journal of Cancer Researcb (CJCR) is an international, peer-reviewed open access (OA) oncological journal published in English bimonthly, and is owned by Chinese Joumal of Cancer Research Co., Ltd and Peking University Cancer Hospital & Institute. It focuses on the aspects of cancer researches mainly including cancer etiology and epidemiology, cellular and molecular biology, biochemistry, immunology, molecular genetics, gene diagnosis and gene therapy, pathology of malignant tumor, research on anti-cancer drugs, imaging diagnosis of cancer, surgical oncology, medical oncology, radiation oncology and biological therapy of cancer, etc.

1. Manuscript Categories

Original Articles

Original scientific reports of clinical research, epidemiological studies, research on molecular biology, etc. Original articles should normally be in the format of Introduction, Materials and Methods,Results and Discussion. The text is limited to 5,000 words excluding the title page, abstract, references, figures, figure legends, and tables. Abstracts are limited to300 words.

Review Articles

Reviews are comprehensive analyses of specific topics. They are submitted upon invitation by the Editors. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance. The text is limited to 5,000 words excluding the title page, abstract, references,figures, figure legends, and tables. Abstracts are limited to 300 words.

Research Highlights

Research Highlights are ‘digest’ of the best/most interesting research findings that have been recently published in the field of cancer research. They are usually solicited by editors and written by outstanding experts. The text is limited to 1,500 words. No abstracts are required.

Perspectives

Perspective articles can be more subjective, forward-looking or speculative. A paper presenting controversial positions or papers of the same topic advocating opposite opinions will be published as Perspectives. Most perspective articles will be solicited by the editors. However, we also welcome timely, unsolicited perspective articles. The text is limited to 5,000 words excluding the title page, abstract, references, figures, figure legends, and tables. Abstracts are limited to300 words.

Technical Notes

Technical notes should present a novel or improved technique, investigation or procedure. The article must describe a demonstrable advance on what is currently available. The text is limited to 2,500 words including abstract, but excluding references, tables and figures. Photos, drawings and videos are encouraged.

Commentaries

Commentaries present a point of view of general interest not related to an article in the same issue of CJCR. The text is limited to 1,500 words. No abstracts are required.

......

更多内容详见:

http://www.cjcrcn.org/data/down/Author_Instruction.pdf

  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭